Sufentanil, a very potent and extremely safe intravenous morphine-like compound in mice, rats and dogs
- PMID: 12772
Sufentanil, a very potent and extremely safe intravenous morphine-like compound in mice, rats and dogs
Abstract
Sufentanil (R 30 730), N-[4-methoxymethyl)-1-[2-(2-thienyl)ethyl]-4-piperidinyl]-N-phenylpropanamide, is a chemically novel, highly potent and extremely safe intravenous morphine-like agent in laboratory animals. In mice R 30 730 i.v. is 2304 times more potent than morphine (hot plate ED50's: 0.0028 and 6.45 mg/kg, respectively). The i.v. safety margin of R 30 730 in mice is 1 : 6 679 (LD50 = 18.7 mg/kg). Under the same experimental conditions the safety margin of pethidine is 1 : 7.97, of morphine 1 : 34.9 and of fentanyl 1 : 454. In rats R 30 730 i.v. is 4521 times more potent than morphine (tail withdrawal test ED50's: 0.00071 and 3.21 mg/kg, respectively). The i.v. safety margin of R 30 730 in rats is 1 : 25 211 (LD50 : 17.9 mg/kg). Under the latter experimental conditions the safety margin of pethidine is 1 : 4.80, of morphine 1 : 69.5 and of fentanyl 1 : 277. In dogs R 30 730 i.v. is 2429 times more potent than morphine (apomorphine antagonism test ED50's: 0.00028 and 0.68 mg/kg, respectively). The i.v. safety margin in dogs is approximately 1 : 50 000, the LD50 being +/- 14.0 mg/kg. All morphine-like effects of R 30 730 are immediately antagonized by nalorphine. These pharmacological findings are relevant in connection to the increasing interest for use of morphinomimetics in anesthesia.
Similar articles
-
N-4-Substituted 1-(2-arylethyl)-4-piperidinyl-N-phenylpropanamides, a novel series of extremely potent analgesics with unusually high safety margin.Arzneimittelforschung. 1976;26(8):1548-51. Arzneimittelforschung. 1976. PMID: 12771
-
Analgesic activity and pharmacological characterization of N-[1-phenylpyrazol-3-yl]-N-[1-(2-phenethyl)-4-piperidyl] propenamide, a new opioid agonist acting peripherally.Eur J Pharmacol. 2008 Oct 24;595(1-3):22-9. doi: 10.1016/j.ejphar.2008.07.052. Epub 2008 Jul 31. Eur J Pharmacol. 2008. PMID: 18706410
-
Pharmacological profile of the new potent neuroleptic ocaperidone (R 79,598).J Pharmacol Exp Ther. 1992 Jan;260(1):146-59. J Pharmacol Exp Ther. 1992. PMID: 1370538
-
The antiemetic effects of domperidone, a novel potent gastrokinetic.Arch Int Pharmacodyn Ther. 1980 Mar;244(1):130-40. Arch Int Pharmacodyn Ther. 1980. PMID: 7416883
-
Respiratory effects of epidural and subcutaneous morphine, meperidine, fentanyl and sufentanil in the rat.Anesth Analg. 1988 Nov;67(11):1071-8. Anesth Analg. 1988. PMID: 2973266
Cited by
-
Sufentanil. A review of its pharmacological properties and therapeutic use.Drugs. 1988 Sep;36(3):286-313. doi: 10.2165/00003495-198836030-00003. Drugs. 1988. PMID: 2903821 Review.
-
Clinical pharmacokinetics of the newer intravenous anaesthetic agents.Clin Pharmacokinet. 1986 Jan-Feb;11(1):18-35. doi: 10.2165/00003088-198611010-00002. Clin Pharmacokinet. 1986. PMID: 3512140 Review.
-
Comparison of Esketamine/Propofol and Sufentanil/Propofol on Intraoperative Hypoxemia During Bronchoscopy: A Randomized Trial.Drug Des Devel Ther. 2025 May 27;19:4429-4436. doi: 10.2147/DDDT.S490423. eCollection 2025. Drug Des Devel Ther. 2025. PMID: 40453215 Free PMC article. Clinical Trial.
-
Effects of different doses of sufentanil and remifentanil combined with propofol in target-controlled infusion on stress reaction in elderly patients.Exp Ther Med. 2013 Mar;5(3):807-812. doi: 10.3892/etm.2013.900. Epub 2013 Jan 17. Exp Ther Med. 2013. PMID: 23407772 Free PMC article.
-
Haemodynamic and plasma vasopressin responses during high-dose fentanyl or sufentanil anaesthesia.Can Anaesth Soc J. 1986 Jul;33(4):475-83. doi: 10.1007/BF03010974. Can Anaesth Soc J. 1986. PMID: 2943380
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources